Letter - Acneiform Rash as a Reaction to Radiotherapy in a Breast Cancer Patient

Conflicts of interest: Y. B., J. R. H., and P. G. have none to declare. M. E. L. has a consultant or advisory role with Bristol Myers Squibb, Boehringer Ingelheim, ImClone/Eli Lilly, Onyx, Bayer, Genzyme, Amgen, and Threshold; has received honoraria from Bristol Myers Squibb, Boehringer Ingelheim, ImClone/Eli Lilly, Onyx, Bayer, Genzyme, Amgen, and Threshold; and is receiving research funding from Hana Biosciences and Onyx Pharmaceuticals.

¹ PubMed ID in brackets